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Serial Analysis of the Gut and Respiratory Microbiome in Cystic
Fibrosis in Infancy: Interaction between Intestinal and Respiratory
Tracts and Impact of Nutritional Exposures
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ABSTRACT Pulmonary damage caused by chronic colonization of the cystic fibrosis (CF) lung by microbial communities is the
proximal cause of respiratory failure. While there has been an effort to document the microbiome of the CF lung in pediatric and
adult patients, little is known regarding the developing microflora in infants. We examined the respiratory and intestinal micro-
biota development in infants with CF from birth to 21 months. Distinct genera dominated in the gut compared to those in the
respiratory tract, yet some bacteria overlapped, demonstrating a core microbiota dominated by Veillonella and Streptococcus.
Bacterial diversity increased significantly over time, with evidence of more rapidly acquired diversity in the respiratory tract.
There was a high degree of concordance between the bacteria that were increasing or decreasing over time in both compart-
ments; in particular, a significant proportion (14/16 genera) increasing in the gut were also increasing in the respiratory tract.
For 7 genera, gut colonization presages their appearance in the respiratory tract. Clustering analysis of respiratory samples indi-
cated profiles of bacteria associated with breast-feeding, and for gut samples, introduction of solid foods even after adjustment
for the time at which the sample was collected. Furthermore, changes in diet also result in altered respiratory microflora, sug-
gesting a link between nutrition and development of microbial communities in the respiratory tract. Our findings suggest that
nutritional factors and gut colonization patterns are determinants of the microbial development of respiratory tract microbiota
in infants with CF and present opportunities for early intervention in CF with altered dietary or probiotic strategies.
IMPORTANCE While efforts have been focused on assessing the microbiome of pediatric and adult cystic fibrosis (CF) patients to
understand how chronic colonization by these microbes contributes to pulmonary damage, little is known regarding the earliest
development of respiratory and gut microflora in infants with CF. Our findings suggest that colonization of the respiratory tract
by microbes is presaged by colonization of the gut and demonstrated a role of nutrition in development of the respiratory micro-
flora. Thus, targeted dietary or probiotic strategies may be an effective means to change the course of the colonization of the CF
lung and thereby improve patient outcomes.
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Cystic fibrosis (CF) is the most common life-limiting auto-somal recessive disease in Caucasians and causes multisystem
complications, with progressive lung disease, pancreatic insuffi-
ciency, and a profound impact on growth and nutrition (1, 2).
Mutations in CFTR are known to alter the airway and intestinal
microenvironment, and patterns of bacterial colonization are dif-
ferent in infants, children, and older adults with CF than in sub-
jects without CF (3–11). The pattern of respiratory and enteric
colonization in children with CF is thought to differ from that in
children without CF beginning in infancy, and colonization with
pathogens including Staphylococcus aureus and Pseudomonas
aeruginosa is associated with worse long-term lung function, more
frequent exacerbations, and earlier morbidity and mortality (1, 9,
12, 13). Recent CF porcine studies have identified that defective
bacterial clearance occurs soon after birth, with early colonization
and impaired eradication resulting in the inflammatory damage of
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lung tissue (14). Chronic colonization of the CF lung by
antibiotic-resistant microbial communities results in progressive
respiratory failure and is the leading cause of mortality in these
patients (1, 13, 15). Because delaying chronic pathogen coloniza-
tion in CF improves clinical outcomes, it is important to under-
stand early patterns of colonization to inform future strategies to
prevent or modify the acquisition of pathogenic colonization (12,
16, 17).
Long-term morbidity and mortality in CF are closely related to
suboptimal nutritional status and growth failure, which further
increase the risk of morbidity and mortality (2, 18), and this nu-
tritional status likely impacts, and is impacted by, the microbiota.
Furthermore, twin studies of CF show that approximately 50% of
disease progression is explained by genetic factors, and approxi-
mately 50% is explained by environmental and/or stochastic ef-
fects that have yet to be further elucidated (11). We hypothesize
that a significant contribution to variable disease expression in
patients with CF who are genetically identical is due to differences
in microbial acquisition and that acquisition of the gut micro-
biome may impact the acquisition of the lung microbiome in in-
fants with CF.
The purpose of this study was to investigate the developing
respiratory and intestinal microbiome in infants with CF, begin-
ning in the first month of life, using culture-independent 454 py-
rosequencing of the bacterial 16S rRNA gene. We studied seven
infants approximately every 3 months up to the first 21 months of
life and compared the acquisition of the microbiome in the gut
and respiratory tract as the infants were exposed to breast milk and
infant formula and introduced to solid foods. The ultimate goal of
this work is to understand how to promote and maintain a micro-
biome that prevents or resists colonization with pathogenic bac-
teria, maintain a more health-promoting microbiota in the gut
and the respiratory tract for a longer period of time, and decrease
morbidity and mortality in patients with CF.
RESULTS
Patient cohort. Seven subjects with CF (diagnosed by newborn
screen, sweat chloride test, and confirmatory genetic testing) were
enrolled in the study within a month of birth. Subjects were fol-
lowed for a total of 9 to 21 months beginning at birth, with sam-
ples collected at regularly scheduled CF clinic visits at 1 month
of age and at 3-month intervals serially. Respiratory samples were
obtained using an oropharyngeal swab, a method that has been
reported to accurately reflect the microbial populations in the
respiratory tract (19), including assessing species in a culture-
independent evaluation of respiratory microbes (20). In particu-
lar, this method is the preferred sampling method for infants who
do not produce sputum and do not undergo bronchoalveolar la-
vage (BAL). Stool served as the source of gastrointestinal samples.
All infants were born in a hospital and hospitalized for 2 days to
7 weeks after birth. Of the seven subjects, one (subject 4) was
delivered at 31 weeks’ gestation and spent 7 weeks in neonatal
intensive care. The remaining six subjects were delivered at full
term. Two subjects (subjects 3 and 4) had meconium ileus imme-
diately after birth and required surgery in the first week of life.
Overall, 59 samples were collected and analyzed: 33 intestinal
samples and 26 respiratory samples.
Eight genera dominate distinct microbial communities of
the upper respiratory tract and gut. 16S rRNA gene pyrose-
quencing of the 59 study samples was conducted, yielding a total
of 1,205,894 sequences, which comprised ~1,500 unique opera-
tional taxonomical units (OTUs) (see Table S1 in the supplemen-
tal material). Among these sequences, which collectively repre-
sented 79 unique genera, 74% and 72% of the total number of
reads across samples were represented by 8 genera for the intesti-
nal and respiratory microbiome samples, respectively (Fig. 1).
Streptococcus, Veillonella, and Prevotella dominated the respira-
tory samples, comprising nearly 60% of the total number of reads
across the respiratory samples (Fig. 1b). Bacteroides, Bifidobacte-
rium, and Veillonella were the most abundant genera in the intes-
tinal tract, collectively comprising 40% of the total number of
reads (Fig. 1d).
We evaluated both the most abundant microbes in the intesti-
nal and respiratory tracts and the inter- and intraindividual vari-
ation in the microbial composition and diversity within these two
sampling locations. As depicted in Figure 1a and c, there is a pat-
tern of lower interindividual variability in the normalized abun-
dance of the eight most dominant genera within the respiratory
tract than in normalized bacterial abundance within the intestinal
tract.
We more formally examined this observation by computing
and comparing the intraclass correlation coefficient (ICC) be-
tween the intestinal and respiratory tracts (Table 1). The ICC is a
statistical measure that captures the intrasubject similarity in nor-
malized microbial abundance. The values of ICC are bounded
between 0 and 1, with values approaching 1 signifying that a
greater proportion of the total variation in normalized microbial
abundance is accounted for by between-subject variation (inter-
subject variation). In this way, the ICC can also be interpreted as
the proportion of total variance in normalized microbial abun-
dance that is “between subjects.” The pairwise comparison of
ICCs for all 77 bacterial genera between the intestinal and respi-
ratory tracts revealed significantly greater (P  0.02) ICCs in the
intestinal tract than in the respiratory tract. These data indicate
that the respiratory microbiome may be more consistent across
the patients than the intestinal populations.
Identifying a core bacterial cluster. Hierarchical clustering of
the 59 samples based on the log10-normalized abundance of the 79
genera identified here revealed that the intestinal and respiratory
samples clustered exclusively into two discrete clusters (Fig. 2, left;
see also Fig. S1 in the supplemental material). A common core of
bacteria are present throughout all sample time points and both
sample types (respiratory and intestinal), with a dominance of
Streptococcus and Veillonella (P  0.05) (Fig. 2, box 1). There are
two significant clusters (Fig. 2, boxes 2 and 4) that are highly
represented in the respiratory tract but not the gut. These data
indicate that while a small group of organisms is present between
the respiratory tract and the gut, these compartments are largely
distinct with respect to their microbial communities.
Select genera in the gut presage microbial populations in the
respiratory tract. Among the subset of microbes present in the
respiratory tract and gut, we noticed a high degree of concordance
between the bacterial genera that were increasing or decreasing
over time in both systems. That is, 14 of 16 genera that were in-
creasing in the gut were also increasing in the respiratory tract (P
 0.001) (Fig. 3A). These data suggest that while the microbiome
of the respiratory tract and gut are distinct (Fig. 1 and 2), there are
some microbes common to both sites whose populations change
similarly over time. Importantly, the respiratory tract changes in-
dicate a large increase in several bacterial genera, the majority of
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which are known to populate the intestines (including Escherichia,
Parabacteroides, and Bifidobacterium; see Fig. S2 in the supple-
mental material). Changes in the relative normalized abundance
of bacteria in the intestines reveal a decrease in Staphylococcus and
Clostridium and an increase in several of the bacteria that also
increase in the respiratory tract, including Escherichia and Para-
bacteroides (see Fig. S2).
Further inspection of the hierarchical clustering analysis re-
vealed a group of microbes present in samples from early life in the
intestines that are also present later in life in the respiratory tract
(Fig. 2, box 3, compare inset a to inset b). This group of bacteria
includes Enterococcus, Coprococcus, Escherichia, and Parabacte-
roides. For 7 genera of bacteria, plotting the populations over time
indicates that gut colonization occurs prior to their appearance in
the respiratory tract (Fig. 3B). Thus, the microbial populations are
dynamic over time, and a subset of genera is detected in the gut
prior to their appearance in the respiratory tract.
Microbial diversity increases over time in both the respira-
tory and intestinal tracts. Microbial diversity, assessed using the
Simpson’s diversity index (SDI) (21), showed subtle but increas-
FIG 1 Bacterial normalized abundance of the respiratory and intestinal microbiomes. (a) Stacked bar plot representing bacterial genera from serial respiratory
microbiome samples from the 7 subjects. The y axis represents the number of reads for particular bacterial genera; the x axis represents subject numbers (1 to 7)
and serial samples at progressive months of life. (b) Pie chart of the eight most abundant genera within the respiratory microbiome. (c) Stacked bar plot
representing bacterial genera from serial intestinal microbiome samples. The y axis represents the number of reads for particular bacterial genera; the x axis
represents subject numbers (1 to 7) and serial samples at progressive months of life. (d) Pie chart of the eight most abundant genera within the intestinal
microbiome.
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ing trends across time among both the respiratory and intestinal
tracts (Fig. 4a and b). We further note that the trends in increasing
microbial diversity appeared to be more pronounced in the respi-
ratory tract (Fig. 4a) than in the intestine (Fig. 4b). We used a
linear mixed-effect model to examine the association between
time and microbial diversity when comparing the respiratory and
intestinal tracts. The results from this model revealed that while
the microbial diversity of both the respiratory and intestinal tracts
increased significantly over time (P  2e4 and P  0.04, respec-
tively), the diversity of the respiratory tract increased more acutely
over time than that of the intestinal tract (P  0.07) (Fig. 4c).
Thus, while both sites are dynamic, the rate of change in the re-
spiratory tract appears to be greater than that observed in the gut
in this cohort.
Characterizing effect of exposures on microbiome develop-
ment. We next assessed the impact of nutritional exposures on
overall diversity and on particular subgroups of microbes. An
analysis of the relationship between nutrition and overall diversity
revealed that nonsignificant diversity trajectories occurred with
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a ICC, intraclass correlation coefficient. The values of ICC are bounded between 0 and
1, with values approaching 1 signifying that a greater proportion of the total variation
in microbial normalized abundance is accounted for by between-subject variation
(intersubject variation). The ICC can also be interpreted as the proportion of total
variance in microbial normalized abundance that is “between subjects.”
FIG 2 Heat map and SDI of the intestinal and respiratory microbiome samples. Heat map based on the hierarchical clustering solution (Euclidean distance
metric and average linkage) of the 59 intestinal and respiratory microbiome samples. Rows represent samples (subjects and respective time points at which the
samples were collected), columns represent genera, and the values in the heat map represent the log10-normalized numbers of sequencing reads, with increasing
grades of purple representing greater relative abundance. Box 1, core microbiome crossing respiratory and intestinal samples across all time points (P  0.05).
Boxes 2 and 4, microbes more abundantly represented in the respiratory microbiome. Box 3, microbes highlighted as having increased normalized abundance
in the intestines early in life (inset a) and in the respiratory tract later in life (inset b), highlighted by a dark-green outline. Box 5, genera more highly represented
in the intestinal samples. Pvclust (http://bioinformatics.oxfordjournals.org/content/22/12/1540.full), a method for assessing the uncertainty in hierarchical
cluster analysis via multiscale bootstrap resampling, was used to determine the significance of identified clusters.
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breast milk compared with results with infant formula, as well as
the introduction of solid foods (Fig. 4d and e). As discussed below,
however, there are significant impacts on specific microbial pop-
ulations in response to these nutritional parameters.
The recursive partitioned mixed-models (RPMM) (22)
method was implemented to cluster samples on the basis of their
microbiome profile and to examine the association between the
resultant clusters and nutritional parameters. Briefly, RPMM is a
hierarchical, model-based methodology for clustering samples on
the basis of their observed normalized microbial abundances
across a collection of genera. RPMM is similar to the well-known
hierarchical clustering; however, given its model-based frame-
work, this analysis requires the specification of a model for the
underlying distribution of normalized microbial abundance. In
our application of RPMM, a Gaussian (i.e., normal) distribution
was assumed and fit to the log10-transformed, normalized micro-
bial abundance data. The resulting RPMM solution provides an
estimate of the number of underlying clusters, as well as the class
membership probabilities for each of the samples within each of
the estimated clusters.
FIG 3 Changes in bacterial relative normalized abundance over time in the CF infant respiratory tract. (a) y axis is the coefficient (Coef) estimate representing
the change in normalized log10 abundance over time. Values below the line represent a decrease in normalized abundance of the indicated bacterial genera over
time (highlighted with red font if a statistically significant change with P  0.05); points above the line represent bacteria that increase in normalized abundance
over time. Blue dots highlight the bacteria at the genus level that are also present in the intestinal tract (P  0.05). (b) y axis is normalized log10 abundance plotted
versus time in months (x axis) for the 7 bacterial genera indicated. The intestinal relative normalized abundance is shown in blue, and the data for the respiratory
samples are red.
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Four clusters were estimated from the RPMM solution applied
to the intestinal microbiome samples only (Fig. 5). Subsequent
statistical analysis revealed a significant association between the
resultant clusters and the initiation of solid foods (permutation
chi-square testing) (Fig. 5). We further examined this association
using a permutation-based logistic regression model that was con-
trolled for time and found that solid food remained statistically
significant (P  0.01).
RPMM was also applied to respiratory samples. Similar to
the intestinal samples, four clusters were estimated from
RPMM (see Fig. S3 in the supplemental material). Statistical
analysis using a permutation chi-square test revealed a signifi-
cant association between the resultant clusters and the start of
solid foods (P  0.02) and breast milk exposure (P  0.05)
(Table 2). A permutation-based logistic regression model con-
trolled for time was fit, and only one variable remained mar-
ginally significant, breast-feeding (P  0.08) (Table 2; see also
Fig. S3).
FIG 4 Trajectories of microbial diversity for the intestinal and respiratory microbiomes. SDIs were arc sine square root transformed (55) to satisfy normality
conditions. (a) Subject-specific and estimated trajectories of the microbial diversity of the respiratory tract as a function of time. (b) Subject-specific and
estimated trajectories of the microbial diversity of the intestinal tract as a function of time. (c) Summarized results of the linear mixed-effects model. (d, e)
Trajectory of microbial diversity for breast milk versus formula (d) and for pre- and post-introduction of solid foods (e).
FIG 5 Heat map based on RPMM solution. The resulting clusters from model-based clustering of intestinal microbiome samples are shown. Rows represent
samples, and columns represent microbes at the genus level, depicting the four clusters that were estimated from the model-based clustering solution. The actual
values represent the mean (within cluster) log10-normalized abundances. Clusters, significantly associated with solid food (P  0.006), adjusting for the time at
which the sample was collected.
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DISCUSSION
Our in-depth study of a limited cohort of infants with CF, using
massively parallel pyrosequencing technology, outlines the devel-
oping microbiome of the respiratory and intestinal tracts in in-
fants with CF. Infants and young children with CF are highly sus-
ceptible to chronic colonization with pathogens and infection,
and we were able to begin to outline their developing microbiome
in detail, laying the groundwork for future studies to better char-
acterize the microbiome in these patients to improve short- and
long-term outcomes. The developing microbiota of the respira-
tory and intestinal tracts in infants with CF are distinct with an
overlapping core and differentially increase in diversity over the
first years of life. There is some concordance between the genera in
both the gut and the respiratory tract and a subset of genera that
are present in the gut prior to colonization of the respiratory tract.
We demonstrate that the majority of the bacteria present in the
respiratory and intestinal tracts were represented by 8 distinct
genera, with overlap between the two organ systems that was re-
flected in a core microbiota dominated by Veillonella and Strepto-
coccus. Our group identified a separate cohort of adult subjects
with CF showing a Streptococcus predominance in sputum sam-
ples, particularly during periods of clinical stability (23). Rogers et
al., using non-culture-based studies, have highlighted two distinct
phyla in the CF lung: the Proteobacteria (Haemophilus influenzae,
P. aeruginosa, Stenotrophomonas maltophilia, and Burkholderia ce-
pacia among others) and the Firmicutes (S. aureus), in addition to
other members of these phyla, including Veillonella, and Strepto-
coccus (24), findings which are mirrored in our study. It is inter-
esting that our cohort of infants and young children with CF mir-
rors studies of adults with CF, where many of the bacteria in the
CF respiratory tract are species that require anaerobic conditions
for growth, such as Veillonella and Prevotella spp. (24–28). For
example, Sibley et al. found that nearly half of the culture CF
airway community in adult sputum was composed of obligate
anaerobes (29).
Sample collection for respiratory microbiota evaluation in-
volved oropharyngeal sampling which mirrors the clinical sam-
ples collected for culture at proscribed time points in the CF clinic.
The oropharyngeal swab method has been reported to accurately
reflect the microbial populations in the lung in CF (19), including
the use to assess species in a culture-independent evaluation of
respiratory microbes (20). In particular, this method is the pre-
ferred sampling method for infants, a population that does not
produce sputum and for which bronchoalveolar lavage is not in-
dicated clinically. Rosenfeld and colleagues analyzed data from
three independent, prospective studies involving simultaneous
collection of 286 oropharyngeal and BAL cultures from 141 chil-
dren with CF under age 5 years (19). The concordance between
the oropharyngeal cultures and simultaneous BAL cultures was
high, with a 95% specificity, although the specificity of oropha-
ryngeal cultures was higher for the presence of P. aeruginosa than
for S. aureus (19). Although there are a limited number of studies
that have investigated infant oral or salivary microbiota, one study
of 5 edentulous infants’ salivary bacterial microbiome identified
that prior to tooth eruption, Streptococcus, Veillonella, and Neisse-
ria were the predominant bacterial genera present (30). This is
similar to the respiratory microbiota we identified with the three
most common genera, including Streptococcus, Veillonella, and
Prevotella. Of particular interest will be the comparison of clinical
cultures with the paired deep-sequencing samples, which is the
focus of the next analysis of this cohort.
We also discovered a surprising pattern of clusters of bacteria,
including potential pathogens such as Enterococcus, that were
present early in life in the gut and later in young life in the respi-
ratory tract, highlighting the potential interrelatedness of these
two organ systems and their microbiota. These findings suggest
time-dependent development of the microflora in each organ sys-
tem with an interaction that might prove to highlight clinically
relevant information for intervention, for example with oral pro-
biotic therapy. These findings are consistent with previous re-
ports, with identification of bacteria in the respiratory tract in CF
that are typically associated with the intestinal cavity (31) and are
theorized to contribute to the continuum of interactions between
the host and microbial community in CF that relates to both the
lung and gut microbiota (24).
Our investigation of the diversity of bacteria over time revealed
the unexpected finding that diversity in the respiratory tract in-
creased more rapidly than that in the intestines in this population.
It has been demonstrated that over time, the intestinal micro-
biome increases in diversity in humans, beginning at birth (32,
33), with transition to the height of diversity by the age of 1 to
3 years, mirroring an adult pattern (33, 34). There have been sev-
eral authors who have identified that lack of microbial diversity, or
an abrupt decrease in microbial diversity, is associated with infec-
tion or disease (3, 35, 36). Conversely, it has been postulated that
the respiratory tract microbiota is not particularly diverse in its
healthy state, and that perhaps increased diversity would be asso-
ciated with infection and morbidity (24). Specific to adults with
CF, investigations into the relationship between CF lung microbi-
ota diversity and lung function have overall pointed to decreased
lung diversity as being inversely proportional to lung function (3,
36, 37), thus overall supporting the idea that several organ systems
have been identified as correlating increased diversity with health
and decreased diversity with disease (3, 35, 36). One study of 8 to
9 years in duration in six adults subjects with CF identified that
diversity decreased over time in parallel with progressive disease
and remained stable in patients with milder lung disease; however,
they identified antibiotic use rather than lung function as the most
significant driver of decreased microbial diversity in sputum sam-
ples (38). Additionally, based on sputum samples, Stressmann et
al. corroborated similar findings for 14 patients with CF that an-
tibiotic use was most associated with decreased microbial diversity
and that overall decreased diversity was correlated to more-severe
lung disease, as well as abundance of Pseudomonas aeruginosa
(28). Further evaluation of predominant pathogens, microbial di-
TABLE 2 Examining the association between RPMM clusters, derived








Histamine blockers 0.004 0.25
Solid food 0.021 0.89
CF exacerbation 0.83 0.52
Antibiotics 0.009 0.55
Breast-feeding 0.05 0.08
Pseudomonas colonization 0.05 0.87
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versity patterns, and clinical outcomes in infants and children
with CF is warranted, since Huang et al. have postulated that the
airway microbiome composition in CF is related to the severity of
disease and that microbial drivers of disease exacerbation are
likely to be identified with new culture-independent techniques
(39).
We characterized the developing microbiome in infants and
children with CF in relation to the common dietary exposures
experienced by this patient population. Interestingly, the effect of
exposures on diversity trajectories over time revealed more signif-
icant effects of breast milk exposure on respiratory tract diversity
than on the gut. The introduction of solid food, as might be ex-
pected, preferentially impacted the intestinal microbiota. These
data highlight the potential mechanisms for understanding pilot
studies of probiotic administration in subjects with CF, linking
alteration of the gut microflora with decreased pulmonary exac-
erbations (40). Breast milk is the gold standard nutrition in the
newborn and infant period, providing significant amounts of Bi-
fidobacterium and Lactobacillus, with significant health-
promoting associations (41–43). Understanding the potential in-
teraction between the developing intestinal microbiota, microbe-
host interactions, and respiratory colonization highlights
potential time points for intervention. However, it is important to
note that at this stage and based on our study, no conclusions can
be drawn regarding any benefits of breast-feeding in this popula-
tion.
Limitations of the study include the small number of subjects
involved and overall small number of sampling time points. An-
other potentially significant limitation, which is particularly rele-
vant in infant populations, is the recently reported difficulty with
culture-independent investigations in detecting bifidobacterial
species as reported by Turroni et al. (44), which is being attributed
to technical biases related to DNA extraction protocols or primers
utilized.
The developing microbiota of the respiratory and intestinal
tracts in infants with CF are distinct with an overlapping core and
differentially increase in diversity over the first years of life. There
are concordances between the genera in both the gut and the re-
spiratory tract and a large number of genera that are present in the
gut prior to colonization of the respiratory tract. Furthermore,
changes in diet also result in altered respiratory microflora, sug-
gesting a link between nutrition and development of microbial
communities in the respiratory tract. Our findings suggest that
nutritional factors and gut colonization patterns are determinants
of microbial development in the respiratory tract in infancy and
present opportunities for early intervention in CF.
MATERIALS AND METHODS
Human subjects, inclusion criteria, and clinical data. Institutional re-
view board (IRB) approval was obtained in April 2010 (Center for the
Protection of Human Subjects at Dartmouth, number 21761), with yearly
renewal of approval in April 2011 and 2012, and parents of subjects pro-
vided written informed consent.
Eligible participants included neonates diagnosed prenatally or imme-
diately postnatally with CF whose care for CF would take place at the
Dartmouth Hitchcock Medical Center in Lebanon, NH, or Manchester,
NH. Subjects were enrolled prior to 1 month of life, with follow-up pro-
spective data and sample collection on an every 1- to 3-month basis until
the age of 21 months. Neonates with clinical syndromes or other chromo-
somal abnormalities were not eligible for the study.
Clinical information collected prospectively included the following:
demographics, prenatal/birth history, and interim medical history (spe-
cifically CF exacerbations using the Akron Children’s Hospital Exacerba-
tion scoring system, growth failure, and hospitalizations for CF-related
disease), as well as height/weight. Clinical culture results were collected
prospectively, along with medical interventions, including medications,
hospitalizations, and detailed dietary and environmental histories. Mater-
nal antibiotic exposure and complete neonatal and infant antibiotic ex-
posure data were collected and analyzed relative to changes in the micro-
biome over time.
Sample collection and storage. Oropharyngeal and stool samples
were collected at regularly scheduled time periods (every 3 months) be-
ginning in the first month of life for up to 2 years during follow-up visits
in the CF clinic. Oropharyngeal swabs were collected at the same time as
the routine surveillance oropharyngeal cultures to minimize the burden
for the participating children in CF clinic. Surveillance throat cultures in
CF patients are screened for the presence of S. aureus and other common
pathogens, such as P. aeruginosa, B. cepacia, and H. influenzae. Each re-
search swab was placed in a 2-ml microcentrifuge tube, and the sample
tubes were capped, stored at 20°C, and transported to the lab on dry ice.
Sterile swab samples were washed in RNALater reagent (Qiagen) and
vortexed, and then samples were divided into two 1-ml samples and fro-
zen at 80. Stool samples were collected by parents at home using a sterile
wooden spatula, placed in a sterile collection cup, and placed on ice or in
the freezer until transport to the lab on ice. In the lab, stool samples were
aliquoted into 250-mg samples in sterile tubes with 1 ml RNAlater and
frozen at 80.
Sample processing. (i) Respiratory samples. Samples were thawed in
batches of 10, and bacterial DNA was extracted immediately upon thaw-
ing. DNA extraction was performed according to published methods (45)
using the Mobio PowerSoil DNA extraction kit (Mobio), utilizing a com-
bination of mechanical and chemical lysis. Sample was loaded into the
PowerBead tube, and a homogenization and lysis procedure was com-
pleted. The PowerBead tube contains a buffer that disperses the sample
and protects nucleic acids from degradation. The mix is vortexed, which
mixes the components of the PowerBead tube and disperses sample in the
PowerBead solution.
(ii) Stool samples. DNA was extracted using the MoBio Powersoil
bacterial DNA isolation kit. Two hundred fifty milligrams of stool sample
was dissolved in RNALater reagent, and then DNA was extracted accord-
ing to the manufacturer’s instructions with details outlined above. The
DNA was used to construct PCR amplicon libraries for sequencing.
Massively parallel sequencing. 454 pyrosequencing was performed at
the Josephine Bay Paul Center, Marine Biological Laboratories. Pyrose-
quencing targeted the 16S rRNA gene using Titanium amplicon sequenc-
ing. A mix of five fusion primers at the 5= end and four primers at the 3=
end of the V6 region were designed to capture the full diversity of rRNA
sequences represented in molecular databases (46, 47). Similarly, fusion
primers with multiple mixed sites were used to amplify the V4 through V6
regions (a single 3= primer with degenerate sites replaced the pool of four
primers used for V6). The V6 data sets are all GS20 and 101.7 nucleotides
(nt), average; the rest are GSFLX titanium and 543.5 nt, average. Taxo-
nomic identifiers were assigned to pyrotags by using the rRNA indexing
algorithm Global Assignment of Sequence Taxonomy (GAST) (48),
which compares pyrotags to known rRNA genes that have already been
placed in a phylogenetic framework of more than 1,000,000 nearly full-
length rRNA reference sequences (RefSSU) on the SILVA database (49).
The tag mapping methodology GAST for taxonomic assignments of en-
vironmental V6 pyrotags and the V4V6 and V6 reference databases are
freely available through the VAMPS (Visualization and Analysis of Micro-
bial Population Structure) website (http://vamps.mbl.edu/resources/faq
.php#gasting). There were no low-biomass concerns from the samples
with sequencing. 16S rRNA gene pyrosequencing of the 59 study samples
was conducted using first the V6 region and ultimately using the V4V6
hypervariable region in the samples. These two analyses were assessed
with regard to their similarities and were not statistically significantly
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different (see Table S2 in the supplemental material), and therefore the
data were pooled for the analyses presented here. A small proportion of
sequences were assigned a terminal rank at the species level (only 41% of
OTUs), and therefore our analysis was focused toward comparisons at the
genus level, for which there was considerably better sequence specificity
(77% of OTUs were classified at the genus level).
Data analysis. Statistical analysis was aimed at examining the richness
and diversity of the intestinal and respiratory microbiome among the
seven neonates in the study from the 59 total samples analyzed. Given the
longitudinal nature of these data, we sought to investigate both how the
richness and diversity of the intestinal and respiratory microbiome
change over time in developing infants with CF and if these changes asso-
ciate with dietary and nutritional factors. Richness was defined as the total
number of taxonomic units (abundance, expressed as the number of
reads) within a sample, and diversity was evaluated using the SDI (50). For






and where nij represents the number of the jth species/organism for the ith
sample and Ni represents the total number of species/organisms for the ith
sample. Thus, the SDI is approximately continuously distributed between
0 and 1, with values approaching 1 signifying greater microbial diversity.
OTUs defined at a 3% sequence difference cutoff were treated as the ter-
minal taxonomical rank. Statistical analyses were applied comprehen-
sively at all phylogenetic ranks (phylum, class, order, family, genus, spe-
cies, and OTU).
Hierarchical clustering using the Euclidean distance metric and aver-
age linkage was used to cluster all samples based on the log10-normalized
abundance for each bacterial taxon. In addition to hierarchical clustering,
samples were also clustered using RPMM (22), a model-based hierarchi-
cal clustering methodology that has been demonstrated to perform effec-
tively and efficiently for clustering high-dimensional array-based
genomic data (51–53). The model-based formulation of RPMM provides
a robust statistical framework for estimating the number of clusters K,
while also providing the posterior probability of class membership for
each sample across each of the K terminal clusters. RPMM was applied to
all samples, to respiratory microbiome samples only, and to intestinal
microbiome samples only. Specifically, a Gaussian-distributed RPMM
was used to cluster samples based on the log10-normalized abundances for
each bacterial taxon using the CRAN R software package RPMM. To
avoid resulting in a sparse data-clustering solution (i.e., a small number of
samples within the resulting clusters), the maximum number of clusters
was restricted to four. The phenotypic relevance of the resulting clusters
was then analyzed using permutation chi-square tests and a permutation-
based logistic regression procedure (54) for robust small-sample infer-
ence. To ensure that the phenotypic relevance of the resulting clusters was
not driven by time, the permutation-based logistic regression models
were adjusted for the time at which the microbiome sample was collected.
The permutation-logistic regression models were fit using the CRAN R
software package logregperm.
Linear mixed-effects models were used to investigate changes in mi-
crobial diversity and normalized bacterial abundance over time and how
these changes related to dietary and nutritional factors. The use of linear
mixed-effects models facilitates the examination of the linear relationship
between two variables when one or more of the subjects being examined
contain repeated measurements. For examining changes in microbial di-
versity over time, the SDI was arc sine square root (55) transformed to
satisfy the assumption of normality.
Transformed SDI was modeled as the response, with fixed-effects
terms including main effects for time (time at which the sample was col-
lected) and sample type (respiratory or intestinal) and the interaction
term and a random effect for subject. A similar strategy was employed for
investigating the relationship between dietary and nutritional factors in
relation to changes in respiratory and intestinal microbial diversity over
time. For examining changes in normalized bacterial abundance over
time, we modeled log10 normalized abundance as the response, with a
fixed term for time and a random effect for patient. All analyses were
implemented in the R software environment (http://cran.r-project.org/),
version 2.13.
Nucleotide sequence accession number. All data generated from se-
quencing have been deposited in the NCBI (National Center for Biotech-
nology Information of the National Institutes of Health and the U.S. Na-
tional Library of Medicine) GenBank (SRA) with accession number
SRP014429.
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